Iwata H - Search Results

1

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.

Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N. Mittendorf EA, et al. Among authors: iwata h. Lancet. 2020 Oct 10;396(10257):1090-1100. doi: 10.1016/S0140-6736(20)31953-X. Epub 2020 Sep 20. Lancet. 2020. PMID: 32966830 Clinical Trial.

2

Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer.

Saji S, Toi M, Morita S, Iwata H, Ito Y, Ohno S, Kobayashi T, Hozumi Y, Sakamoto J. Saji S, et al. Among authors: iwata h. Oncology. 2007;72(5-6):330-7. doi: 10.1159/000113062. Epub 2008 Jan 12. Oncology. 2007. PMID: 18187954 Clinical Trial.

3

A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.

Hayashi H, Kimura M, Yoshimoto N, Tsuzuki M, Tsunoda N, Fujita T, Yamashita T, Iwata H. Hayashi H, et al. Among authors: iwata h. Breast Cancer. 2009;16(2):136-40. doi: 10.1007/s12282-008-0060-1. Epub 2008 Jun 12. Breast Cancer. 2009. PMID: 18548321

4

Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.

Suzuki Y, Tokuda Y, Fujiwara Y, Iwata H, Sasaki Y, Saji S, Aogi K, Nambu Y, Suri A, Saeki T, Takashima S. Suzuki Y, et al. Among authors: iwata h. Jpn J Clin Oncol. 2009 Nov;39(11):699-706. doi: 10.1093/jjco/hyp103. Epub 2009 Sep 22. Jpn J Clin Oncol. 2009. PMID: 19776022 Clinical Trial.

5

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.

Barrios CH, Liu MC, Lee SC, Vanlemmens L, Ferrero JM, Tabei T, Pivot X, Iwata H, Aogi K, Lugo-Quintana R, Harbeck N, Brickman MJ, Zhang K, Kern KA, Martin M. Barrios CH, et al. Among authors: iwata h. Breast Cancer Res Treat. 2010 May;121(1):121-31. doi: 10.1007/s10549-010-0788-0. Epub 2010 Mar 26. Breast Cancer Res Treat. 2010. PMID: 20339913 Free PMC article. Clinical Trial.

6

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer.

Sawaki M, Iwata H, Sato Y, Wada M, Toyama T, Sasaki E, Yatabe Y, Imai T, Ohashi Y. Sawaki M, et al. Among authors: iwata h. Breast. 2010 Oct;19(5):370-6. doi: 10.1016/j.breast.2010.03.021. Epub 2010 May 15. Breast. 2010. PMID: 20472435 Free article. Clinical Trial.

7

Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.

Iwata H, Sato N, Masuda N, Nakamura S, Yamamoto N, Kuroi K, Kurosumi M, Tsuda H, Akiyama F, Ohashi Y, Toi M. Iwata H, et al. Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081. Jpn J Clin Oncol. 2011. PMID: 21719750 Clinical Trial.

8

Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer.

Takada M, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Ueno T, Sasano H, Toi M. Takada M, et al. Among authors: iwata h. Breast. 2012 Feb;21(1):40-5. doi: 10.1016/j.breast.2011.07.015. Epub 2011 Aug 19. Breast. 2012. PMID: 21855342 Free article.

9

Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen.

Fujiwara Y, Takatsuka Y, Imoto S, Inaji H, Ikeda T, Akiyama F, Tamura M, Miyoshi K, Iwata H, Mitsuyama S, Noguchi S. Fujiwara Y, et al. Among authors: iwata h. Cancer Sci. 2012 Mar;103(3):491-6. doi: 10.1111/j.1349-7006.2011.02171.x. Epub 2012 Jan 13. Cancer Sci. 2012. PMID: 22136317 Free PMC article. Clinical Trial.

10

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

Nakamura S, Ando M, Masuda N, Aogi K, Ino H, Iwata H, Tokuda Y, Yamamoto N, Kasai H, Takeuchi M, Tsuda H, Akiyama F, Kurosumi M, Fujiwara Y. Nakamura S, et al. Among authors: iwata h. Clin Breast Cancer. 2012 Feb;12(1):49-56. doi: 10.1016/j.clbc.2011.10.002. Epub 2011 Dec 6. Clin Breast Cancer. 2012. PMID: 22154118 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,968 results

Search Page